39, Rue Camille Desmoulins
Villejuif 94805
France
33 09 72 22 67 08
https://www.predilife.com
Secteur(s): Healthcare
Secteur d’activité: Diagnostics & Research
Employés à temps plein: 18
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Stephane Ragusa | Founder, President, CEO & Chairman | 150k | S.O. | 1970 |
Mr. Émilien Gauthier | Chief Technical Officer and R&D Director | S.O. | S.O. | S.O. |
Marion Renelier | Legal Director | S.O. | S.O. | S.O. |
Anne Kerzan | Chief Marketing Officer | S.O. | S.O. | S.O. |
Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.
L’ISS Governance QualityScore de Predilife S.A. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..